Nuwellis (NUWE) Revenue & Revenue Breakdown
Nuwellis Revenue Highlights
Latest Revenue (Y)
$8.86M
Latest Revenue (Q)
$2.19M
Nuwellis Revenue by Period
Nuwellis Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $8.86M | 3.76% |
2022-12-31 | $8.54M | 7.85% |
2021-12-31 | $7.92M | 6.45% |
2020-12-31 | $7.44M | 35.02% |
2019-12-31 | $5.51M | 10.26% |
2018-12-31 | $5.00M | 40.67% |
2017-12-31 | $3.55M | 175.64% |
2016-12-31 | $1.29M | 2084.75% |
2015-12-31 | $59.00K | -80.00% |
2014-12-31 | $295.00K | 400.00% |
2013-12-31 | $59.00K | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | -100.00% |
2010-06-30 | $400.03K | 269.36% |
2009-06-30 | $108.30K | -74.34% |
2008-06-30 | $422.04K | -84.55% |
2007-06-30 | $2.73M | 117.99% |
2006-06-30 | $1.25M | 228.25% |
2005-06-30 | $381.76K | 1529.23% |
2004-06-30 | $23.43K | - |
Nuwellis Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $2.19M | 18.15% |
2024-03-31 | $1.86M | -27.21% |
2023-12-31 | $2.55M | 5.76% |
2023-09-30 | $2.41M | 16.24% |
2023-06-30 | $2.08M | 13.64% |
2023-03-31 | $1.83M | -21.93% |
2022-12-31 | $2.34M | 13.27% |
2022-09-30 | $2.06M | -6.69% |
2022-06-30 | $2.21M | 14.90% |
2022-03-31 | $1.93M | 17.30% |
2021-12-31 | $1.64M | -11.39% |
2021-09-30 | $1.85M | -26.12% |
2021-06-30 | $2.51M | 30.76% |
2021-03-31 | $1.92M | -6.16% |
2020-12-31 | $2.04M | 7.35% |
2020-09-30 | $1.90M | 2.20% |
2020-06-30 | $1.86M | 14.29% |
2020-03-31 | $1.63M | 19.24% |
2019-12-31 | $1.37M | 9.19% |
2019-09-30 | $1.25M | -25.34% |
2019-06-30 | $1.68M | 38.02% |
2019-03-31 | $1.22M | -18.95% |
2018-12-31 | $1.50M | 9.98% |
2018-09-30 | $1.36M | 24.02% |
2018-06-30 | $1.10M | 5.98% |
2018-03-31 | $1.04M | 24.79% |
2017-12-31 | $831.00K | -13.17% |
2017-09-30 | $957.00K | 10.76% |
2017-06-30 | $864.00K | -4.11% |
2017-03-31 | $901.00K | 20.78% |
2016-12-31 | $746.00K | 37.38% |
2016-09-30 | $543.00K | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | -100.00% |
2015-03-31 | $59.00K | -66.67% |
2014-12-31 | $177.00K | 200.00% |
2014-09-30 | $59.00K | 100.00% |
2014-06-30 | - | -100.00% |
2014-03-31 | $59.00K | 100.00% |
2013-12-31 | - | -100.00% |
2013-09-30 | $59.00K | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | -100.00% |
2011-09-30 | $-50.00K | - |
Nuwellis Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HSCS | Heart Test Laboratories | $18.60M | $14.70K |
NUWE | Nuwellis | $8.86M | $2.19M |
RSLS | ReShape Lifesciences | $8.68M | $1.97M |
INVO | INVO Bioscience | $3.02M | $1.58M |
TNON | Tenon Medical | $2.93M | $719.00K |
SINT | Sintx | $2.63M | $687.00K |
NAOV | NanoVibronix | $2.28M | $817.00K |
TIVC | Tivic Health Systems | $1.18M | $140.00K |
HSDT | Helius Medical | $644.00K | $182.00K |
TLIS | Talis Biomedical | $412.00K | - |
BJDX | Bluejay Diagnostics | - | - |
BBLG | Bone Biologics | - | - |
NUWE Revenue FAQ
What is Nuwellis’s yearly revenue?
Nuwellis's yearly revenue for 2023 was $8.86M, representing an increase of 3.76% compared to 2022. The company's yearly revenue for 2022 was $8.54M, representing an increase of 7.85% compared to 2021. NUWE's yearly revenue for 2021 was $7.92M, representing an increase of 6.45% compared to 2020.
What is Nuwellis’s quarterly revenue?
Nuwellis's quarterly revenue for Q2 2024 was $2.19M, a 18.15% increase from the previous quarter (Q1 2024), and a 5.73% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.86M, a -27.21% decrease from the previous quarter (Q4 2023), and a 1.70% increase year-over-year (Q1 2023). NUWE's quarterly revenue for Q4 2023 was $2.55M, a 5.76% increase from the previous quarter (Q3 2023), and a 9.06% increase year-over-year (Q4 2022).
What is Nuwellis’s revenue growth rate?
Nuwellis's revenue growth rate for the last 3 years (2021-2023) was 11.91%, and for the last 5 years (2019-2023) was 60.84%.